Abstract
Renal cell carcinoma (RCC) accounts for 3% of all adult cancers. The incidence rates for kidney cancer are highest in European and Scandinavian countries and North America (1). It is estimated that 36,160 new cases of kidney and renal pelvis cancer were diagnosed in 2005, with an estimated 12,660 resulting deaths in the United States (2). There has been a 30% increase in incidence in the last 20 years. Although this increased incidence is partly a result of more widespread and aggressive imaging, current reports show a real increase in incidence. Renal cell carcinoma is a tumor of adults occurring primarily after the 5th decade of life. It occurs one-and-a-half times as often in men as in women (3:2) (3). Childhood RCC is uncommon, representing only 2% to 6% of all renal tumors in children. Bilateral tumors are identified in 2% to 5% of the patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Parkin DM, Muir CS, Whelan S, et al. Cancer Incidence in Five Continents, vol VI. IARC Scientific Publication No. 120. Lyon, France: World Health Organization, International Agency for Research on Cancer, 1992.
Jemal A, Murray T, Ward E, et al. Cancer statistics 2005. CA Cancer J Clin 2005; 55:10–30.
Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics 1999. CA Cancer J Clin 1999;49:8–31.
Choyke PL, Glenn GM, Walther MM, et al. State of the art: hereditary renal cancers. Radiology 2002;226:33–46.
Bergstrom A, Hsieh CC, Lindblad P, et al. Obesity and renal cell cancer—a quantitative review. Br J Cancer 2001;85:984–990.
Srikanth MS, Fox SR, Oh KH, et al. Renal cell carcinoma following bariatric surgery. Obes Surg 2005;15(8):1165–1170.
Lindblad P, Chow WH, Chan J, et al. The role of diabetes mellitus in the etiology of renal cell cancer. Diabetologia 1999;42(1):107–121.
Kirkali Z, Obek C. Clinical aspects of renal cell carcinoma. EAU Update Ser 2003;1: 189–198.
Lindner V, Lang H, Jacqmin D. Pathology and genetics in renal cell cancer. Eur Urol 2003; suppl 1:197–208.
Lee CT, Katz J, Shi W, et al. Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol 2000;163:730–736.
Bosniak MA, Birnbaum BA, Krinsky GA, et al. Small renal parenchymal neoplasms: further observations on growth. Radiology 1995;197:589–597.
Wu SL, Kothari P, Wheeler TM, Reese T, et al. Cytokeartins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas. Mod Pathol 2002; 15:712–717.
Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655–663.
Linehan WM, Lerman MI, Zbar B. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. JAMA 1995;273:564–570.
Linehan WM, Grubb RL, Coleman JA, et al. The genetic basis of kidney cancer: implications for gene specific clinical management. BJU Int 2005;95(suppl 2):2–7.
Pavlovich CP, Grubb RL 3rd, Hurley K, et al. Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome. J Urol 2005;173:1482–1486.
Isreal GM, Bosniak MA. Renal imaging for diagnosis and staging of renal cell carcinoma. Urol Clin North Am 2003;30:499–514.
Shvarts O, Lam JS, Kim L, Belldegrun AS. Staging of renal cell carcinoma: current concepts. BJU Int 2005;95(suppl 2):8–13.
Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 2001;166:63–67.
Lang H, Jacqmin D. Prognostic factors in renal cell carcinoma. Eur Urol Update Ser 2003;1(4):215–219.
Pantuck AJ, Zisman A, Rauch MK, Belldegrun AS. Incidental renal tumors. Urology 2000;56:190–196.
Campbell S, Novick A. Expanding the indications for elective nephrectomy: Is this advisable? Eur Urol 2006;49:952–954.
Becker F, Siemer S, Hack M, et al. Excellent long-term cancer control with elective nephron saving surgery for selected renal cell carcinomas measuring more than 4cm. Eur Urol 2006;49:1058–1064.
Uzo RG, Novick AC. Nephron-saving surgery for renal tumors: indications, techniques and outcomes. J Urol 2001;166:6–18.
Wickham JE. Conservative renal surgery for adenocarcinoma. The place of bench surgery. Br J Urol 1975;47:25–36.
Weld JK, Landman J. Comparison of cryoablation, radiofrequency ablation, land HIFU for treating small renal tumors. BJU Int 2005;96:1224–1229.
Hofmann HS, Neef H, Krohe K, et al. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol 2005;48:77–81.
Romis L, Cindolo L, Patard JJ, et al. Frequency, clinical presentation and evolution of renal oncocytomas: multicentric experience from a European database. Eur Urol 2004;45:53–57.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag London Limited
About this chapter
Cite this chapter
Kirkali, Z., Cal, C. (2008). Renal Cell Carcinoma: Overview. In: Nargund, V.H., Raghavan, D., Sandler, H.M. (eds) Urological Oncology. Springer, London. https://doi.org/10.1007/978-1-84628-738-1_14
Download citation
DOI: https://doi.org/10.1007/978-1-84628-738-1_14
Publisher Name: Springer, London
Print ISBN: 978-1-84628-387-1
Online ISBN: 978-1-84628-738-1
eBook Packages: MedicineMedicine (R0)